Riskpilot← Back to searchSign inGet full accessCitoLimbus AB
ABActiveOrg 5569956021LundOther financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 20140 employees
Revenue 2025
SEK 0
EBITDA margin
—
+46% vs 2024
Equity ratio
98.6%
Financial strength
Net profit 2025
SEK -24K
-56% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -9K | +46% |
| Net profit | SEK -24K | -56% |
| Total assets | SEK 872K | -21% |
| Equity | SEK 860K | -21% |
| Employees | 0 | — |
Legal name
CitoLimbus AB
Org number
5569956021
Legal form
Aktiebolag
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
12 december 2014
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanterna
Company purpose
Nationella och internationella mätningar, modelleringar och analyser av biologiska naturresurser, samt utbildning och rådgivning i resursfrågor. Äga och förvalta fast och lös egendom.
Address
Lund
Email
info@bolagspartner.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | −0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −34 | −8 | −15 | −16 | −9 |
| Depreciation & amort. | −28 | −16 | −12 | −0 | — |
| EBIT | −62 | −24 | −27 | −16 | −9 |
| Net financials | 110 | −80 | 100 | 1 | −15 |
| Profit before tax | 47 | −103 | 73 | −15 | −24 |
| Tax | −0 | — | — | — | — |
| Net profit | 47 | −103 | 73 | −15 | −24 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 725 | 1 426 | 1 311 | 1 100 | 872 |
| Equity | 1 701 | 1 414 | 1 299 | 1 088 | 860 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 24 | 12 | 12 | 12 | 12 |
| Total debt | 24 | 12 | 12 | 12 | 12 |
EBITDA margin
-864700.0%
This company
15.8%
Market median
-5472885% vs market
20212025
Equity ratio
98.6%
This company
38.2%
Market median
+158% vs market
20212025
Return on equity
-2.8%
This company
18.4%
Market median
-115% vs market
20212025
Net profit margin
-2381200.0%
This company
8.1%
Market median
-29397631% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
KE Chief Executive Officer | Chief Executive Officer | 2022 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2026 | |
| Deputy Board Member | 2026 | |
| Board of Directors | 2026 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CitoLimbus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjell Ebbe Wallin | Chief Executive Officer | 0 companies |
| Nils Göran Cederlund | Deputy Board Member | 0 companies |
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Karl-Johan Staffan Tångby | Board of Directors | 0 companies |